Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study
Publication
, Conference
Voorhees, PM; Gasparetto, C; Osman, K; Richards, KL; Ferraro, M; Garcia, R; MacLean, J; Winans, D; Moore, D; Strader, J; Orlowski, RZ; Hurd, DD
Published in: BLOOD
November 18, 2011
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
1705 / 1706
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Voorhees, P. M., Gasparetto, C., Osman, K., Richards, K. L., Ferraro, M., Garcia, R., … Hurd, D. D. (2011). Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study. In BLOOD (Vol. 118, pp. 1705–1706). San Diego, CA: AMER SOC HEMATOLOGY.
Voorhees, Peter M., Cristina Gasparetto, Keren Osman, Kristy L. Richards, Madlyn Ferraro, Reynaldo Garcia, Jennifer MacLean, et al. “Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study.” In BLOOD, 118:1705–6. AMER SOC HEMATOLOGY, 2011.
Voorhees PM, Gasparetto C, Osman K, Richards KL, Ferraro M, Garcia R, et al. Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1705–6.
Voorhees, Peter M., et al. “Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 1705–06.
Voorhees PM, Gasparetto C, Osman K, Richards KL, Ferraro M, Garcia R, MacLean J, Winans D, Moore D, Strader J, Orlowski RZ, Hurd DD. Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1705–1706.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 18, 2011
Volume
118
Issue
21
Start / End Page
1705 / 1706
Location
San Diego, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology